Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Kardiologia Polska
|
January 30, 2020
Anthracycline-induced cardiotoxicity prevention with angiotensin-converting enzyme inhibitor ramipril in women with low-risk breast cancer: results of a prospective randomized study
Agnieszka Słowik, Paweł Jagielski, Paweł Potocki, et al.
International Journal of Surgery (London, England)
|
November 24, 2016
Do we really need the full compliance with ERAS protocol in laparoscopic colorectal surgery? A prospective cohort study
Magdalena Pisarska, Michał Pędziwiatr, Piotr Małczak, et al.
Cancers
|
August 29, 2024
Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study
Miroslawa Püsküllüoğlu, Marek Ziobro, Joanna Lompart, et al.
Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques
|
August 7, 2014
Enhanced recovery (ERAS) protocol in patients undergoing laparoscopic total gastrectomy
Michał Pędziwiatr, Maciej Matłok, Mikhail Kisialeuski, et al.
Experimental and Therapeutic Medicine
|
September 20, 2024
Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab
Sebastian Ochenduszko, Lamberto Landete, David Collado Martinez, et al.
Journal of Clinical Medicine
|
November 27, 2024
Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer
Mirosława Püsküllüoğlu, Marek Ziobro, Małgorzata Pieniążek, et al.
Oncology Letters
|
January 21, 2016
Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature
Joanna Streb, Miroslawa Püsküllüoğlu, Izabela Glanowska, et al.
Medical Oncology (Northwood, London, England)
|
September 11, 2015
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial
Sebastian Ochenduszko, Miroslawa Puskulluoglu, Kamil Konopka, et al.
Oncotargets and Therapy
|
December 6, 2021
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
Mª Del Carmen Álamo, Sebastian Ochenduszko, Guillermo Crespo, et al.
Nature Communications
|
December 2, 2021
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial
Maria Gonzalez-Cao, Clara Mayo de Las Casas, Juana Oramas, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Kardiologia Polska
|
January 30, 2020
Anthracycline-induced cardiotoxicity prevention with angiotensin-converting enzyme inhibitor ramipril in women with low-risk breast cancer: results of a prospective randomized study
Agnieszka Słowik, Paweł Jagielski, Paweł Potocki, et al.
International Journal of Surgery (London, England)
|
November 24, 2016
Do we really need the full compliance with ERAS protocol in laparoscopic colorectal surgery? A prospective cohort study
Magdalena Pisarska, Michał Pędziwiatr, Piotr Małczak, et al.
Cancers
|
August 29, 2024
Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study
Miroslawa Püsküllüoğlu, Marek Ziobro, Joanna Lompart, et al.
Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques
|
August 7, 2014
Enhanced recovery (ERAS) protocol in patients undergoing laparoscopic total gastrectomy
Michał Pędziwiatr, Maciej Matłok, Mikhail Kisialeuski, et al.
Experimental and Therapeutic Medicine
|
September 20, 2024
Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab
Sebastian Ochenduszko, Lamberto Landete, David Collado Martinez, et al.
Journal of Clinical Medicine
|
November 27, 2024
Time from Final Oncologist Visit to Death and Palliative Systemic Treatment Use Near the End of Life in Heavily Pretreated Patients with Luminal Breast Cancer
Mirosława Püsküllüoğlu, Marek Ziobro, Małgorzata Pieniążek, et al.
Oncology Letters
|
January 21, 2016
Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature
Joanna Streb, Miroslawa Püsküllüoğlu, Izabela Glanowska, et al.
Medical Oncology (Northwood, London, England)
|
September 11, 2015
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial
Sebastian Ochenduszko, Miroslawa Puskulluoglu, Kamil Konopka, et al.
Oncotargets and Therapy
|
December 6, 2021
Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
Mª Del Carmen Álamo, Sebastian Ochenduszko, Guillermo Crespo, et al.
Nature Communications
|
December 2, 2021
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial
Maria Gonzalez-Cao, Clara Mayo de Las Casas, Juana Oramas, et al.
Page
of 3